Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 1/2 1

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Cancer Metastatic 3Neoplasm Metastasis 2Uveal Melanoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neurofibromatosis 2 1Neoplasms 1Macular Degeneration 1Lung Neoplasms 1Colorectal Neoplasms 1Carcinoma 1

Interventions

aflibercept 3Irinotecan 2Bevacizumab 2XELOX 1Vemurafenib 1Panitumumab 1Leucovorin 1IFL protocol 1Fluorouracil 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Colorectal Cancer Metastatic × aflibercept × Clear all
NCT01571284 2018-04-17

Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Sanofi

Phase 3 Completed
781 enrolled 28 charts
Gastrointestinal

Colorectal Cancer Metastatic

NCT01670721 2016-11-28

AFEQT

Sanofi

Phase 3 Completed
175 enrolled 6 charts
Gastrointestinal

Colorectal Cancer Metastatic

NCT01661270 2016-10-18

AFLAME

Sanofi

Phase 3 Completed
332 enrolled 9 charts
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡